Literature DB >> 15607792

Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation.

Ann Sophie Franki1, Katrien Van Beneden, Pieter Dewint, Ivan Meeus, Eric Veys, Dieter Deforce, Dirk Elewaut.   

Abstract

Lymphotoxin (LT) alpha 1 beta 2, a tumour necrosis factor (TNF) cytokine critically involved in lymphoid organogenesis, is indispensable for the differentiation of V alpha 14i natural killer T (NKT) cells, a lymphocyte subset with important immunoregulatory properties. However, it is not required for the development of conventional T-cells. LT alpha 1 beta 2 signals through the LT beta receptor, which is expressed on non-lymphoid cells. Triggering of this receptor induces a unique signalling cascade leading to the activation of the transcription factor RelB through activation of NF-kappa B inducing kinase. This pathway is required for V alpha 14i NKT cell differentiation as appears from studies in gene-deficient animals. By reciprocal bone marrow chimeras, it was shown that RelB is required in a radiation-resistant host cell or stromal cell for normal V alpha 14i NKT cell development, presumably in the thymic stroma. These stromal cells are not required for the positive selection of these cells but rather play a prominent role in their terminal differentiation. Altogether, these observations underscore the unique developmental requirements of this particular lymphocyte subset.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607792     DOI: 10.1016/j.molimm.2004.07.020

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 2.  Stromal-cell regulation of natural killer cell differentiation.

Authors:  Claude Roth; Carla Rothlin; Sylvain Riou; David H Raulet; Greg Lemke
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

3.  IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells.

Authors:  Eleanor Clancy-Thompson; Lestat Ali; Patrick T Bruck; Mark A Exley; Richard S Blumberg; Glenn Dranoff; Michael Dougan; Stephanie K Dougan
Journal:  Cancer Immunol Res       Date:  2017-11-29       Impact factor: 11.151

4.  Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients.

Authors:  Kyoung Un Park; Ping Jin; Marianna Sabatino; Ji Feng; Sara Civini; Hanh Khuu; Maria Berg; Richard Childs; David Stroncek
Journal:  J Immunother       Date:  2010 Nov-Dec       Impact factor: 4.456

Review 5.  APECED: A Paradigm of Complex Interactions between Genetic Background and Susceptibility Factors.

Authors:  Lucia De Martino; Donatella Capalbo; Nicola Improda; Federica D'Elia; Raffaella Di Mase; Roberta D'Assante; Ida D'Acunzo; Claudio Pignata; Mariacarolina Salerno
Journal:  Front Immunol       Date:  2013-10-23       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.